Augmentation Strategies in Treatment-Resistant Depression CME/CE

Author Information and Disclosures

Release Date: May 30, 2008; Valid for credit through May 30, 2009

Credits Available
Physicians - maximum of 0.25 AMA PRA Category 1 Credit(s)™ for physicians;
Nurses - 0.25 nursing contact hours (0.25 contact hours are in the area of pharmacology)

To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.

Contents of This CME/CE Activity

Downloadable Slides
Augmentation Strategies in Treatment-Resistant Depression
Powerpoint presentation by Maurizio Fava, MD

Legal Disclaimer

The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

Copyright © 2008 Medscape.
BMS, Otsuka
Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Review the epidemiology, definition, and clinical treatments available for treatment resistant depression
  2. Assess the benefits and limitations of existing therapeutic strategies and therapies for depression
  3. Discuss new data regarding the augmentation of current antidepressant therapies
Authors and Disclosures

Maurizio Fava, MD
Disclosure: Maurizio Fava, MD, has disclosed no relevant financial relationships.


Robert Chevrier
Disclosure: Robert Chevrier has disclosed no relevant financial relationships.
 
Medscape
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Medscape, LLC designates this educational activity for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider

 
This Activity is sponsored by Medscape Continuing Education Provider Unit.

Medscape is an approved provider of continuing nursing education by the New York State Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.

Awarded 0.25 contact hour(s) of continuing nursing education for RNs and APNs; 0.25 contact hours are in the area of pharmacology.

Provider Number: 6FDKKC-PRV-05

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.